Description
Linaclotide is prescribed to adults for the management of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). IBS-C is characterized by abdominal discomfort, bloating, and infrequent or challenging bowel movements, while CIC involves infrequent or difficult bowel movements lasting for three months or more, unrelated to an underlying condition or medication. Linaclotide is classified as a guanylate cyclase-C agonist medication. Its mechanism of action involves enhancing the movement of food and waste through the stomach and intestines.